Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors

Product is added to your Wishlist
Global Cancer Imaging Systems Market

Global Cancer Imaging Systems Market - Analysis and Forecast (2017-2025) Focus on Products (Analog Mammography, Digital Breast Tomosynthesis, Molecular Breast Imaging, MRI, CT, PET, and others), Cancer Types, End Users, 26 Country Analysis, Patent Analysis, Market Share Analysis, Growth Share Matrix, and Competitive Landscape

The cancer imaging systems market is growing at an exponential rate with the increasing incidence of various types of cancer and active research and developmental activities dedicated to the continuous advancement in the imaging modalities. With the rising incidence of various types of cancer such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of cancer imaging systems market.

SKU: BH033A
Published Year: 2017
 
 

The cancer imaging system plays a significant role in the detection of cancer as it provides a detailed insight into the exact location and extent of the disease. It also provides detailed information about the structural or cancer related changes. The cancer imaging system not only helps in the detection of the tumour, but also helps in the evaluation of therapeutic & post-therapeutic changes, complications of treatments and follow-up for finding the early detection of recurrence. The medical experts believe that most of the cancer types can be dealt effectively if detected early. Moreover, the emerging methods of molecular imaging which combine the traditional imaging technology and nuclear medicine techniques can also be used to obtain more detailed information about abnormalities, including their distinct metabolism.

This research study includes an extensive analysis of the global cancer imaging systems market, by product, application, end-user and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments have been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and the key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, growth share matrix, competitive benchmarking, and the position of the competitors within the global cancer imaging systems market. 

The following key questions have been addressed in the report:

•    What are the major market drivers, challenges and opportunities of the global cancer imaging systems market?
•    How the cancer imaging systems evolve and what is its scope in the future?
•    What are the market shares of the leading segments and sub-segments of the global cancer imaging systems market in 2016 and 2025?
•    How will each segment of the global cancer imaging systems market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
•    How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
•    How will the industry evolve during the forecast period between 2017 and 2025?
•    What are the key developmental strategies implemented by the key players to stand out in this market?
•    How the market has been segmented on the basis of products, application, end-user and region? 
•    Which product, application and end-user will dominate the global cancer imaging systems market by the end of the forecast period and which one is growing at the highest CAGR during the forecast period 2017-2025?
•    What will be the growth rate of different segments during the forecast period? Which is the leading segment by product, application, end-user and region?
•    Who are the key players for the cancer imaging systems market?
•    Which geographical region will lead the global cancer imaging systems market by the end of the forecast period?
•    Which country is growing at the highest CAGR during the forecast period?

The key players which have significant contributions to the cancer imaging systems market are Siemens Healthineers, GE Healthcare, Hologic Inc., Toshiba Medical Corporation, Hitachi Medical Systems, Gamma Medica Inc., Philips Healthcare, Carestream Health, Fujifilm Holdings Corporation, Konica Minolta, Neusoft Medical, Samsung Medison Co. Ltd and Shimadzu Corporation among others.

TABLE OF CONTENT
Executive Summary
1 Report Scope and Methodology
1.1. Scope of the Report
1.2. Global Cancer Imaging Systems Market Segmentation
1.3 Key Learnings
1.4 Research Methodology
1.4.1. Data Triangulation
1.4.2. Key Data Points from Secondary Sources
1.4.3. Secondary Data Sources 
1.4.4. Key Data Points From Primary Sources 
1.4.5. Top-Down  Approach (Segmental Analysis)
1.4.6. Bottom-Up Approach (Segmental Analysis)
1.4.7. Assumptions and Limitations
1.4.8 Data and Prediction Modelling
2 Market Overview
2.1 Overview
2.2 Important Facts 
2.3 Estimated Number of New Cases of Cancer and Deaths by Gender, U.S., 2017
2.4 Discovery of Medical Imaging Modalities  
2.5 Developments in imaging modalities 
2.6 Role of Imaging in Oncology Decision Process
2.7 Radiation Risk
2.8 Potential Benefits & Risks of Medical Imaging 
2.9 Recent Developments 
3 Market Dynamics 
3.1 Overview
3.2 Market Drivers
3.3. Market Challenges
3.4 Market Opportunities
4 Competitive Landscape
4.1. Key Development and Strategies
4.1.1 New Product Launches and Developments
4.1.2 Patents, Approvals and Certifications 
4.1.3 Business Expansions/Contracts 
4.1.4 Collaborations, Joint Ventures and Partnerships
4.1.5 Others
4.2. Emerging Trends in Medical Imaging Technology 
4.3 Legal Requirements and Regulations
4.4 Market Share Analysis 
4.5 Analysis 
4.6 Growth Share Matrix
4.7 Analysis 
5 Industry Analysis
5.1 Patent Landscape
5.2.  Consortiums, Associations, and Regulatory Bodies
5.3 Analysis- Assumption & Limitations 
6 Global Cancer Imaging Systems Market, by Product
6.1.  Overview
6.2 Mammography 
6.2.1 Analog Mammography 
6.2.2 Full Field Digital Mammography 
6.2.3 Digital Breast Tomosynthesis (DBT)
6.2.4 Some of the Key Market Players  
6.3 Computed Tomography 
6.4 Molecular Breast Imaging (MBI)
6.5 Magnetic Resonance Imaging (MRI)
6.6 Positron Emission Tomography (PET)
6.7 Ultrasound
6.8 Others 
7 Global Cancer Imaging Systems Market, by Cancer Types
7.1 Overview
7.2 Breast Cancer 
7.3 Lung Cancer 
7.4 Prostate Cancer
7.5 Colorectal Cancer
7.6 Liver Cancer 
7.7 Other Cancers 
8 Global Cancer Imaging Systems Market, by End-User
8.1 Overview
8.2 Hospitals 
8.3 End-User
8.4 Others
9 Global Cancer Imaging Systems Market, by Region
9.1 Overview
9.2 North America 
9.2.1 North America by Country Analysis 
9.2.2 The U.S.
9.2.3 Canada 
9.3 Europe
9.3.1 Europe by Country Analysis 
9.3.2 Germany
9.3.3 France
9.3.4 The U.K.
9.3.5 Italy
9.3.6 Spain
9.3.7 Netherlands
9.3.8 Belgium
9.3.9 Rest of Europe
9.4 Asia-Pacific 
9.4.1 Asia-Pacific by Country Analysis 
9.4.2 Japan
9.4.3 China
9.4.4 Australia 
9.4.5 South Korea 
9.4.6 India
9.4.7 Malaysia 
9.4.8 Indonesia 
9.4.9 Rest of Asia-Pacific 
9.5 Latin America 
9.5.1 Latin America by Country Analysis 
9.5.2 Brazil
9.5.3 Mexico
9.5.4 Rest of Latin America 
9.6 Rest of World (RoW)
9.6.1 Rest of the World by Country Analysis 
9.6.2 Russia 
9.6.3 Saudi Arabia 
9.6.4 Israel
9.6.5 South Africa 
9.6.6 United Arab Emirates (UAE)
9.6.7 Rest of RoW
10 Company Profiles
10.1 Carestream Health
10.1.1 Overview
10.1.2 Product Mapping 
10.1.3 Overall Summary
10.1.4 SWOT Analysis 
10.2 Dilon Diagnostics 
10.2.1 Overview
10.2.2 Product Mapping
10.2.3 Overall Summary
10.2.4 SWOT Analysis 
10.3 Esaote
10.3.1 Overview
10.3.2 Product Mapping
10.3.3 Overall Summary
10.3.4 SWOT Analysis 
10.4 Fujifilm Holdings Corporation 
10.4.1 Overview
10.4.2 Product Mapping
10.4.3 Financials 
10.4.3.1 Financial Summary 
10.4.4 SWOT Analysis 
10.5 Gamma Medica Inc. 
10.5.1 Overview
10.5.2 Product Mapping 
10.5.3 Overall Summary 
10.5.4  SWOT Analysis 
10.6 GE Healthcare 
10.6.1 Overview: GE Healthcare 
10.6.2 Overview: General Electric
10.6.3 Product Mapping
10.6.4 Financials 
10.6.4.1 Finacial Summary
10.6.5 SWOT Analysis 
10.7 Hitachi Medical Corporation
10.7.1 Overview: Hitachi Medical Corporation
10.7.2 Overview: Hitachi
10.7.3 Financials 
10.7.3.1 Finacial Summary
10.7.4 SWOT Analysis 
10.8 Hologic Inc.
10.8.1 Overview
10.8.2 Product Mapping
10.8.3 Financials
10.8.3.1 Financial Summary 
10.8.4 SWOT Analysis 
10.9 Konica Minolta
10.9.1 Overview
10.9.2 Product Mapping
10.9.3 Financials
10.9.3.1 Financial Summary 
10.9.4 SWOT Analysis 
10.10 Neusoft Medical
10.10.1 Overview: Neusoft Medical
10.10.2 Overview: Neusoft Corporation
10.10.3 Product Mapping
10.10.4 Financials 
10.10.4.1 Financial Summary 
10.10.5 SWOT Analysis 
10.11 Philips Group 
10.11.1 Overview
10.11.2 Product Mapping
10.11.3 Financials 
10.11.3.1 Financial Summary 
10.11.4 SWOT Analysis 
10.12 Samsung Medison Co. Ltd.
10.12.1 Overview: Samsung Medison Co. Ltd.
10.12.2 Overview: Samsung Electronics Co. Ltd.
10.12.3 Product Mapping
10.12.4 Financials 
10.12.4.1 Financial Summary 
10.12.5 SWOT Analysis 
10.13 Shimadzu Corporation
10.13.1 Overview
10.13.2 Product Mapping
10.13.3 Financials 
10.13.3.1 Financial Summary 
10.13.4 SWOT Analysis 
10.14 Siemens Healthineers 
10.14.1 Overview: Siemens Healthineers 
10.14.2 Overview: Siemens 
10.14.3 Product Mapping
10.14.4 Financials
10.14.4.1 Financial Summary
10.14.5 SWOT Analysis 
10.15 Toshiba Medical Corporation
10.15.1 Overview: Toshiba Medical Corporation
10.15.2 Overview: Canon Inc.
10.15.3 Product Mapping
10.15.4 Financials
10.15.4.1 Financial Summary
10.15.5 SWOT Analysis 
10.16 Analogic Corporation
10.16.1 Overview
10.17 Aurora Imaging Technology, Inc.
10.17.1  Overview
10.18 Bruker Corporation
10.18.1 Overview
10.19 Koning Corporation
10.19.1 Overview
10.20 MR Solutions 
10.20.1 Overview
10.21 NCD Company 
10.21.1 Overview
10.22 Perkin Elmer 
10.22.1 Overview
10.23 Planmed Oy
10.23.1 Overview
10.24 Spectrum Medical Imaging 
10.24.1 Overview
10.25 UMG/DEL Medical Imaging 
10.25.1 Overview
10.26 Varian Medical Systems 
10.26.1 Overview
List of Tables
1 Difference Between Screening Test and Diagnostic Test 
2 Cancer Types Patient Data 
3 Imaging Procedures & Their Approximate Effective Radiation Doses 
4 New Product Launches and Developments 
5 Patents, Approvals and Certifications 
6 Business Expansions/Contracts 
7 Collaborations, Joint Ventures & Partnerships
8 Other Strategies
9 Patent Landscape
10 Consortiums, Associations and Regulatory Bodies
11 Global Cancer Imaging Systems Market by Product, 2016-2025 ($Million)
12 Mammogram Screening Reported, 2014-2015
13 APAC Mammogram Units Reported, 2014
14 CT Scan Volume Data, 2015  
15 MRI (Some of the National Average Billings)
16 MRI Scan Volume data, 2015
17 Breast Cancer Patient Data in Top Countries, (2014-2021)
18 The U.S. Breast Screening Data 
19 Lung Cancer Patient Data in Top Countries, (2014-2021)
20 Summary of prostate cancer imaging modalities   
21 Prostate Cancer Patient Data in Top Countries, (2014-2021)
22 Colorectal Cancer Patient Data  in Top Countries, (2014-2021)
23 Liver Cancer Patient Data in Top Countries, (2014-2021)
24 Stomach Cancer Patient Data in Top Countries, (2014-2021) 
25 Total Number of Hospitals   
26 Total Number of U.S. Outpatient Diagnostic Imaging Centres   
27 CT installation in ambulatory care services
28 MRI installation in ambulatory care services
29 European Key Market Players 
30 Installed Modalities in India, 2015 
31 Overview: Carestream Health
32 Overview: Dilon Diagnostics 
33 Overview: Esaote
34 Overview: Fujifilm Holdings Corporation 
35 Overview: Gamma Medica Inc.
36 Overview: GE Healthcare 
37 Overvie: General Electric 
38 Overview:  Hitachi Medical Corporation
39 Overview: Hitachi
40 Overview: Holgic Inc.
41 Overview: Konica Minolta 
42 Overview:  Neusoft Medical 
43 Overview: Neusoft Corporation
44 Overview: Philips Group
45 Overview: Samsung Medison Co. Ltd.
46 Overview:  Samsung Electronics Co. Ltd.
47 Overview: Shimadzu Corporation
48 Overview: Siemens Healthineers 
49 Overview: Siemens
50 Overview: Toshiba Medical Corporation
51 Overview: Canon Inc.
52 Overview: Analogic Corporation
53 Overview: Aurora Imaging Technology, Inc.
54 Overview: Bruker Corporation 
55 Overview: Koning Corporation 
56 Overview: MR Solutions 
57 Overview: NCD Company
58 Overview: Perkin Elmer
59 Overview: Planmed Oy
60 Overview: Spectrum Medical Imaging 
61 UMG/DEL Medical Imaging
62 Varian Medical Systems 
List of Figures
1 Cancer Imaging Systems  Drivers & Challenges 
2 Cancer Imaging Systems Market Share by Product, 2016
3 Cancer Imaging Systems Market Share by Product, 2025
4 Global Cancer Imaging Systems Market by Product Growth Rate (2017-2025)
5 Cancer Imaging Systems Market Share by Application, 2016
6 Cancer Imaging Systems Market Share by Application, 2025
7 Global Cancer Imaging Systems Market by Application Growth Rate (2017-2025)
8 Cancer Imaging Systems Market Share by End-User, 2016
9 Cancer Imaging Systems Market Share by End-User, 2025
10 Global Cancer Imaging Systems Market by End-User Growth Rate (2017-2025)
11 Global Cancer Imaging Systems Market Share by Region, 2016
12 Global Cancer Imaging Systems Market Share by Region, 2025
13 Global Cancer Imaging Systems Market by Geographical Growth Rate (2017-2025)
14 Global Cancer Imaging Systems Market by Countries Growth Rate (2017-2025)
15 Global Cancer Imaging Systems Market Value by Region, 2016 & 2025 ($Million
16 Global Cancer Imaging Systems Market Segmentation
17 Research Methodology
18 Data Traingulation
19 Key Data Points From Secondary Sources 
20 Secondary Data Sources
21 Key Data Points From Primary Sources 
22 Top-Down  Approach (Segmental Analysis)
23 Bottom-Up Approach (Segmental Analysis)
24 Assumptions and Limitations
25 Data and Prediction Modelling
26 Important Facts 
27 Estimated Number of New Cases of Cancer and Deaths by Gender, U.S., 2017
28 Discovery of Medical Imaging Modalities  
29 Potential Benefits & Risks of Medical Imaging    
30 Market Dynamics
31 Market Drivers
32 Market Challenges
33 Market Opportunities
34 Recent Market Development Strategy Snapshot Analysis
35 Key Market Developments & Strategies
36 Emerging Trends in Medical Imaging Technology 
37 Diagnostic Imaging Market Share by Company, 2015
38 Diagnostic Imaging Market Share by Company, 2016
39 Growth Share Matrix
40 Global Cancer Imaging Systems Market by Product 
41 Analog Mammography Cancer Imaging Systems Market, 2016-2025 ($Million)
42 Global Cancer Imaging Analog Mammography Market by Region, 2016-2025 ($Million)
43 Full Field Digital Mammography Cancer Imaging Systems Market, 2016-2025 ($Million)
44 Global Cancer Imaging Full Field Digital Mammography  Market by Region, 2016-2025 ($Million)
45 Digital Breast Tomosynthesis Cancer Imaging Systems Market, 2016-2025 ($Million)
46 Global Cancer Imaging Digital Breast Tomosynthesis  Market by Region, 2016-2025 ($Million)
47 Pros & Cons of Conventional Mammography Technique
48 Pros & Cons of Digital Mammography
49 Tumor Size Indicators 
50 Palpable Nodes Indicators 
51 Metastasis Indicators 
52 Mammography Units per Million Population (OECD countries) 2015
53 Computed Tomography Cancer Imaging Systems Market, 2016-2025 ($Million)
54 Global Cancer Imaging Computed Tomography Market by Region, 2016-2025 ($Million)
55 Use of CT in cancer imaging 
56 CT Units per Million Population (OECD countries) 2015
57 Molecular Breast Imaging Cancer Imaging Systems Market, 2016-2025 ($Million)
58 Global Cancer Imaging Molecular Breast Imaging Market by Geography, 2016-2025 ($Million)
59 Breast Density 
60 Causes for Growth of  Dense Breast Tissues 
61 Certain Pros & Cons of Molecular Breast Imaging (MBI)  
62 Magnetic Resonance Imaging Cancer Imaging Systems Market, 2016-2025 ($Million)
63 Global Cancer Imaging Magnetic Resonance Imaging Market by Geography, 2016-2025 ($Million)
64 Types of MRI
65 MRI Units Per Million Population (OECD countries 2015)
66 Positron Emission Tomography Cancer Imaging Systems Market, 2016-2025 ($Million)
67 Global Cancer Imaging Positron Emission Tomography Market by Geography, 2016-2025 ($Million)
68 Uses of PET Scan 
69 Some of the Tracers Used in PET
70 Application Area of PET (%)
71 PET Scanner 
72 PET Scan Image  
73 Pros & Cons of PET 
74 Ultrasound Cancer Imaging Systems Market, 2016-2025 ($Million)
75 Global Cancer Imaging Ultrasound Market by Geography, 2016-2025 ($Million)
76 Common Ultrasound Imaging Procedures 
77 Advantages & Disadvantages of Ultrasound 
78 Other Products in the Cancer Imaging Systems Market, 2016-2025 ($Million)
79 Global Cancer Imaging Other Products Market by Geography, 2016-2025 ($Million)
80 Global Cancer Imaging Market by Cancer Types
81 Global Cancer Imaging Systems Market by Application, 2016-2025 ($Million) 
82 Breast Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
83 Percentage of New Breast Cancer Cases by Age Group (2010-2014)
84 Breast Cancer Patient Data (2016)
85 Imaging Modalities Used for Breast Cancer 
86 Lung Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
87 Stages of Non-Small Cell Lung Cancer  
88 Imaging Modalities Used for Lung Cancer 
89 Prostate Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
90 Prostate Cancer Patient Data (2016)
91 Colorectal Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
92 Imaging Modalities Used for Colorectal Cancer 
93 Colorectal cancer by Age
94 Colorectal Cancer Patient Data (2016)
95 Liver Cancer Application Cancer Imaging Systems Market, 2016-2025 ($Million)
96 Liver Cancer Patient Data (2016)
97 Imaging Modalities Used for Liver Cancer 
98 Other Cancers Application Cancer Imaging Systems Market, 2016-2025 ($Million)
99 Cancer imaging Systems Market by End-User  
100 Global Cancer Imaging Systems Market by End-Users, 2016-2025 ($Million) 
101 Hospitals Cancer Imaging Systems Market, 2016-2025 ($Million)
102 Global Cancer Imaging Hospitals Market by Application, 2016-2025 ($Million)
103 Diagnostic Imaging Centers Cancer Imaging Systems Market, 2016-2025 ($Million)
104 Global Cancer Imaging Diagnostic Imaging Centers Market by Application, 2016-2025 ($Million)
105 Other End-User Cancer Imaging Systems Market, 2016-2025 ($Million)
106 Global Cancer Imaging Others Market by Application, 2016-2025 ($Million)
107 Global Scenario 
108 Global Cancer Imaging Systems Market by Region, 2016-2025 ($Million)
109 North America Cancer Imaging Systems Market, 2016-2025 ($Million)
110 North America Cancer Imaging Systems Market by Country, 2016-2025 ($Million)
111 U.S. Cancer Imaging System Market, 2016-2025 ($Million)
112 Canada Cancer Imaging System Market, 2016-2025 ($Million)
113 Cancer Patient Data by Cancers Type in the U.S. (2016
114 Cancer Patient Data by Cancers Type in Canada (2016)
115 Europe Cancer Imaging Systems Market, 2016-2025 ($Million)
116 Europe Cancer Imaging Systems Market by Country, 2016-2025($Million)
117 Germany Cancer Imaging System Market, 2016-2025 ($Million)
118 France Cancer Imaging System Market, 2016-2025 ($Million)
119 U.K. Cancer Imaging System Market, 2016-2025 ($Million)
120 Italy Cancer Imaging System Market, 2016-2025 ($Million)
121 Spain Cancer Imaging System Market, 2016-2025 ($Million)
122 Netherlands Cancer Imaging System Market, 2016-2025 ($Million)
123 Belgium Cancer Imaging System Market, 2016-2025 ($Million)
124 Rest of Europe Cancer Imaging System Market, 2016-2025 ($Million)
125 Key Market Drivers in the European Countries 
126 Denmark-Cancer Patient Data  
127 Germany-Cancer Patient Data (2016
128 France-Cancer Patient Data (2016)
129 Italy- Cancer Patient Data (2016)
130 Market Dynamics (Europe)
131 Asia-Pacific Cancer Imaging Systems Market , 2016-2025 ($Million)
132 Asia-Pacific Cancer Imaging Systems Market by Country, 2016-2025($Million)
133 Japan Cancer Imaging System Market, 2016-2025 ($Million)
134 China Cancer Imaging System Market, 2016-2025 ($Million)
135 Australia Cancer Imaging System Market, 2016-2025 ($Million)
136 South Korea Cancer Imaging System Market, 2016-2025 ($Million)
137 India Cancer Imaging System Market, 2016-2025 ($Million)
138 Malaysia Cancer Imaging System Market, 2016-2025 ($Million)
139 Japan Cancer Patient Data, 2016
140 China-Cancer Patient Data, 2016
141 Installed Modalities in India, 2015 
142 India-Cancer Patient Data,2016
143 Latin America Cancer Imaging Systems Market , 2016-2025 ($Million)
144 Latin America Cancer Imaging Systems Market by Country, 2016-2025($Million)
145 Brazil Cancer Imaging System Market, 2016-2025 ($Million)
146 Mexico Cancer Imaging System Market, 2016-2025 ($Million)
147 Rest of Latin America Cancer Imaging System Market, 2016-2025 ($Million)
148 Rest of World Cancer Imaging Systems Market , 2016-2025 ($Million)
149 RoW Cancer Imaging Systems Market by Country, 2016-2025($Million)
150 Russia Cancer Imaging System Market, 2016-2025 ($Million)
151 Saudi Arabia Cancer Imaging System Market, 2016-2025 ($Million)
152 Israel Cancer Imaging System Market, 2016-2025 ($Million)
153 South Africa Cancer Imaging System Market, 2016-2025 ($Million)
154 United Arab Emirates (UAE) Cancer Imaging System Market, 2016-2025 ($Million)
155 Rest of RoW Cancer Imaging System Market, 2016-2025 ($Million)
156 Qatar Cancer Patient Data,2016
157 Israel-Cancer Patient Data,2016
158 Egypt-Cancer Patient Data,2016
159 Saudi Arabia- Cancer Patient Data ,2016
160 Carestream Health: Product Mapping
161 Carestream Health: SWOT Analysis 
162 Dilon Diagnostics: Product Mapping
163 Dilon Diagnostics: SWOT Analysis 
164 Esaote: Product Mapping
165 Esaote: SWOT Analysis 
166 Fujifilm Holdings Corporation: Product Mapping
167 Fujifilm Holdings Corporation: Overall Financials (2014-2016)
168 Fujifilm Holdings Corporation: Net Revenue by Business Segment (2014-2016)
169 Fujifilm Holdings Corporation: Net Revenue by Business Sub-segment (2016)
170 Fujifilm Holdings Corporation: Net Revenue by Region (2014-2016)
171 Fujifilm Holdings Corporation: SWOT Analysis
172 Gamma Medica Inc.: Product Mapping
173 Gamma Medica Inc.: SWOT Analysis
174 General Electric: Product Mapping
175 General Electric: Overall Financials (2014-2016)
176 General Electric: Net Revenue by Business Segment (2014-2016)
177 General Electric: Net Revenue by Business Sub-Segment (2016)
178 General Electric: Net Revenue by Region (2014-2016)
179 General Electric: SWOT Analysis
180 Hitachi: Product Mapping
181 Hitachi: Overall Financials (2014-2016)
182 Hitachi: Net Revenue by Region (2014-2016)
183 Hitachi: Net Revenue by Business Segment (2014)
184 Hitachi: Net Revenue by Business Segment (2015-2016)
185 Hitachi: SWOT Analysis
186 Hologic Inc.: Product Mapping
187 Hologic Inc.: Overall Financials (2014-2016)
188 Hologic Inc.: Net Revenue by Business Segment (2014-2016)
189 Hologic Inc.: Net Revenue by Region (2014-2016)
190 Hologic Inc.: SWOT Analysis
191 Konica Minolta: Product Mapping 
192 Konica Minolta: Overall Financials (2014-2016)
193 Konica Minolta: Net Revenue by Business Segment (2014-2016)
194 Konica Minolta: Net Revenue by Geography  (2014-2016)
195 Konica Minolta: Net Revenue by Geography  (2014-2016)
196 Neusoft Corporation: Product Mapping
197 Neusoft Corporation: Overall Financials  (2014-2016)
198 Neusoft Corporation: SWOT Analysis 
199 Philips Group: Product Mapping
200 Philips Group: Overall Financial Performance (2014-2016)
201 Philips Group: Net Revenue by Business Segment (2015-2016)
202 Philips Group: Net Revenue by Geography (2014-2016)
203 Philips Group: Net Revenue by Business segment (2014)
204 Philips Group: Diagnostics & Treatment Sub-Segment% (2016)
205 Philips Group: SWOT Analysis
206 Samsung: Product Mapping
207 Samsung: Overall Financials (2014-2016)
208 Samsung: Net Revenue by Business Segment (2014-2016)
209 Samsung: Net Revenue by Region (2014-2016)
210 Samsung: SWOT Analysis 
211 Shimadzu Corporation: Product Mapping
212 Shimadzu Corporation: Overall Financials (2014-2016)
213 Shimadzu Corporation: Net Revenue by Business Segment (2014-2016)
214 Shimadzu Corporation: Net Revenue by Geography (2014-2016)
215 Shimadzu Corporation: SWOT Analysis
216 Siemens Healthineers: Product Mapping
217 Siemens Healthineers: Overall Financials (2014-2016)
218 Siemens Healthineers: Net Revenue by Region (2014-2016)
219 Siemens Healthineers: Net Revenue by Business Segment (2014-2016)
220 Siemens Healthineers: SWOT Analysis
221 Canon Inc. (Toshiba Medical Corporation): Product Mapping
222 Canon Inc. (Toshiba Medical Corporation): Overall Financials (2014-2016)
223 Canon Inc. (Toshiba Medical Corporation): Net Revenue by Business Segment (2014-2016)
224 Canon Inc. (Toshiba Medical Corporation): Net Revenue by Region  (2014-2016)
225 Canon Inc. (Toshiba Medical Corporation): SWOT Analysis

Cancer is one of the leading causes of mortality and morbidity worldwide and according to World Health Organization (WHO), the number of new cases is expected to rise by about 70% over the next 2 decades. Cancer is a broad term for a class of disease characterized by abnormal cells that grow and invade healthy cells in the body. The cancer begins in the cells which are the basic building blocks that make up tissue. It begins with genetic changes impairing this orderly process. Cells start to grow uncontrollably and these cells may form a mass termed as tumor.

The cancer imaging systems market is growing at an exponential rate with the increasing incidence of various types of cancer and active research and developmental activities dedicated to the continuous advancement in the imaging modalities. With the rising incidence of various types of cancer such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of cancer imaging systems market. Furthermore, advancements in digital imaging techniques, growing awareness among the patients about early detection of cancer, and active support of the government has boosted the overall growth of this market. Moreover, the expansion of digital imaging modalities to newer clinical areas, active research and developmental activities in medical imaging, rapid transition of hospitals to promote automatic workflow integration in their current work environment and rising installation base of advanced medical imaging tools in various multispecialty hospitals, is further expected to accentuate the growth of this market in the near future.

However, certain restraining factors such as side effects of radiation exposure, shortage of skilled professionals and high installation cost of cancer imaging systems might hamper the growth of this market. Similarly, unfavorable taxation and lack of favorable reimbursement policies from the European and Asian governments have also negatively impacted the growth of this market.

The new range of companies are striving hard to file patents and get approvals from the regulatory bodies in this growing market and launch innovative products, while the established companies are busy in acquiring companies and partnerships with other ecosystem players.

The global cancer imaging systems is expected to reach $11 billion by 2025. The cancer imaging market broadly focuses on major cancer indications (breast cancer, lung cancer, colorectal cancer and prostate cancer, among others) and various imaging modalities (mammography, MRI and positron emission tomography, among others). The cancer imaging systems have become one of the major potential tools in early cancer detection and diagnostics radiology and also help in decreasing the mortality rate due to cancer.

The product segment of this market comprises of various cancer imaging modalities such as analog mammography, full field digital mammography, digital breast tomosynthesis (DBT), ultrasound, computed tomography (CT), molecular breast imaging (MBI), magnetic resonance imaging (MRI) and positron emission tomography (PET), among others. The ultrasound acquired the highest market value and growing at a CAGR of 3.7%. The reason for such strong market share is attributed to the advantages provided by ultrasound system such as precision in identifying the nature of lesion, less expensive and free from exposure to radiations, active participation of government and industry players in continuous technological development, among others.

The application segment of this market comprises of oncology indications such as breast, lung, colorectal, prostate, liver and other cancers. The breast cancer acquired the highest market value. However, lung cancer is growing at the highest CAGR 5.4%. The reason for such strong market share is attributed to the rising incidence rate of breast cancer among the women all over the world.

The end user segment comprises of hospitals and diagnostic imaging centers, among others. The hospitals segment acquired the highest market value and growing at a CAGR of 4.2%. However, the others segment comprising of physician office and ambulatory services, among others, is growing at the highest CAGR of 6%. Hospitals, which are the major buyers of cancer imaging systems are increasing significantly. Due to the growing geriatric population, rising prevalence of cancer and continuous technological advancements in imaging modalities, there is an increasing demand of imaging technologies both from the health workers and patients, in order to meet the growing volume of cancer patients.

North America is dominating the market in 2016 and is growing at a CAGR of 4.3% during the forecast period. While, Latin America is growing at a CAGR of 6.7% from 2017 to 2025. The key players in the global cancer imaging systems market are Siemens Healthineers, Hologic Corporation, GE Healthcare, Philips Healthcare, Toshiba Medical Corporation, Hitachi Medical, Konica Minolta, Carestream Health and Yangzhou Kindsway Biotech Co. Ltd., among others. The market players are getting into the strategies such as collaborations, partnership & joint ventures, business expansion & contracts, product launches & developments, patents approvals & certifications, and mergers & acquisitions, among others.

The product launch & development strategy dominates the market, followed by regulatory approvals & certification strategy. The companies are busy in new product launches and developments in order to sustain their position and to enhance their business strength and outreach. The market is growing at a very high rate with a strong potential and sustainability. The market players are actively involved in the research and development of more technological advanced imaging modalities to save time, money and life. Along with the existing drivers of the market, the manufacturing of low cost imaging systems, automated image analysis techniques and fusion of two or three imaging modalities are some of the potential opportunities for the market players to sustain a strong position in the cancer imaging systems market.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields

OUR HAPPY CLIENTS


related reports

 

OUR CLIENTS